Filing Details

Accession Number:
0001562180-20-003352
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-05 16:05:43
Reporting Period:
2020-05-01
Accepted Time:
2020-05-05 16:05:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304048 Joanne Smith-Farrell C/O Bluebird Bio, Inc.
60 Binney Street
Cambridge MA 02142
Chief Business Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-01 1,433 $0.00 22,826 No 4 A Direct
Common Stock Disposition 2020-05-04 172 $49.88 22,654 No 4 S Direct
Common Stock Disposition 2020-05-04 45 $50.81 22,609 No 4 S Direct
Common Stock Disposition 2020-05-04 15 $51.57 22,594 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Restricted stock units for common stock to vest on a monthly basis over a 12-month period with a vesting commencement date on May 1, 2020.
  2. Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  3. The range in prices for the transaction reported on this line was $49.34 to $50.32. The average weighted price was $49.8772. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The range in prices for the transaction reported on this line was $50.37 to $51.20. The average weighted price was $50.8112. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The range in prices for the transaction reported on this line was $51.39 to $51.71. The average weighted price was $51.5703. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.